[HTML][HTML] Global treatment outcomes of extensively drug-resistant tuberculosis in adults: A systematic review and meta-analysis

OS Pedersen, FB Holmgaard, MKD Mikkelsen… - Journal of Infection, 2023 - Elsevier
Introduction Historically, extensively drug-resistant tuberculosis has been notoriously difficult
to treat with devasting outcomes. As we are coming to the end of an era where the 2006 …

Assessment of factors associated with unfavorable outcomes among drug-resistant TB patients: A 6-year retrospective study from Pakistan

FU Khan, AU Rehman, FU Khan, K Hayat… - International Journal of …, 2022 - mdpi.com
The spread of drug-resistant tuberculosis (DR TB) poses significant challenges to the control
and successful eradication of TB globally. The current retrospective study was designed to …

Factors associated with unfavorable treatment outcomes among multidrug-resistant tuberculosis patients, Sierra Leone: a cross-sectional secondary data analysis

JA Koroma, AH Elduma, U Sesay, GN Gebru - BMC Infectious Diseases, 2024 - Springer
Background Globally, multidrug-resistant tuberculosis (MDR-TB) is a major public health
problem. The tuberculosis rate in Sierra Leone is 298 per 100,000 people, and Sierra Leone …

[HTML][HTML] Factores asociados al tratamiento no exitoso para tuberculosis en pacientes previamente tratados en Cali, Colombia, en el periodo 2015-2019

L Varela, J Ortiz, PK García, L Luna, JF Fuertes-Bucheli… - Biomédica, 2023 - scielo.org.co
Introducción. Las tasas de éxito del tratamiento de la tuberculosis continúan siendo
subóptimas. Objetivo. Identificar los factores asociados al tratamiento no exitoso para …

Metabolite Dysregulation by Pranlukast in Mycobacterium tuberculosis

SD Yelamanchi, ST Arun Kumar, A Mishra… - Molecules, 2022 - mdpi.com
Mycobacterium tuberculosis has been infecting millions of people worldwide over the years,
causing tuberculosis. Drugs targeting distinct cellular mechanisms including synthesis of the …

Treatment Outcomes and Associated Influencing Factors Among Patients with Rifampicin-Resistant Tuberculosis: A Multicenter, Retrospective, Cohort Study in China

L Zou, W Kang, C Guo, J Du, Q Chen, Z Shi… - Infection and Drug …, 2024 - Taylor & Francis
Objective Rifampin-resistant tuberculosis (RR-TB) remains a serious global public health
concern. We assessed treatment outcomes and associated influencing factors among RR …

Socioepidemiological status and clinical outcome of MDR TB patients in a tertiary medical college in Southern Odisha

M Dash, BP Behera - Journal of family medicine and primary care, 2022 - journals.lww.com
Objectives: Socioepidemiological status and clinical outcome of MDR TB patients in a
teaching hospital in tribal area of southern Odisha from 2012-2020. Material and Methods …

Development and validation of a nomogram for the prediction of unfavorable treatment outcome among multi-drug resistant tuberculosis patients in north west Ethiopia …

DT Anley, TY Akalu, MW Merid… - Infection and Drug …, 2022 - Taylor & Francis
Background Multidrug-resistant tuberculosis (MDR-TB) is a global problem and a health
security threat, which makes “Ending the global TB epidemic in 2035” unachievable …

Tuberculosis treatment outcomes and associated factors: A retrospective study in West Nusa Tenggara, Indonesia

M Meiyanti, A Bachtiar, RK Kusumaratna, A Alfiyyah… - Narra J, 2024 - narraj.org
Successfully treating tuberculosis (TB) could significantly help reduce its spread. The aim of
this study was to identify factors associated with successful TB treatment. A retrospective …

[HTML][HTML] Tratamiento para tuberculosis resistente a rifampicina o multirresistente: análisis comparativo de indicadores programáticos entre Buenaventura y otros …

D Hoyos, R Meza, L Forero, C Moreira, BE Ferro… - Biomédica, 2024 - scielo.org.co
Introducción. El manejo adecuado de la tuberculosis multirresistente es una estrategia
priorizada para el control de la tuberculosis en el mundo. Objetivo. Evaluar las diferencias …